Free tool
Mega cap stocks
We cover 22 companies in the mega cap size band. The median market value in the group is $263.59B. Across the group, the median move over the past trading day is +0.97%. 86% of the 22 with a 200-day average trade above it. Price change over the past year runs from −9.9% to +72.5% across the middle 80 percent of the group, with a median of +29.5%.
Other lists in this group
Table
22 of 300 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% | Oct 29, 2026 |
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% | Oct 29, 2026 |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | 132.16 EUR | +14.19% | +47.92% | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% | Oct 29, 2026 |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% | Oct 27, 2026 |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $440.34 | +12.02% | +36.35% | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | 382.20 EUR | +10.65% | +39.41% | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% | Oct 14, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.